Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05841563 · ClinicalTrials.gov registry record · Phase 1

Clinical Trial of PM54 in Advanced Solid Tumors Patients.

A Phase 1 study of Advanced Solid Tumor, sponsored by PharmaMar.

Recruiting
Registry status
Phase 1
Development phase
125
Enrollment target
3
Study locations

NCT05841563 is a Phase 1 study of Advanced Solid Tumor that is actively recruiting participants, run by PharmaMar. The registered enrollment target is 125 participants, below the 192-participant average among 189 other Advanced Solid Tumor trials with a reported enrollment target (35% lower). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05841563, a Phase 1 study of Advanced Solid Tumor, is actively recruiting participants, sponsored by PharmaMar.

RECRUITING
Registry status
Phase 1
Development phase
125 participants
Enrollment target
3
Study locations

Study Summary

The first part of the study (phase Ia - dose escalation) will evaluate the safety and tolerability and identify the dose-limiting toxicities (DLTs) of PM54. The second part of the study (phase Ib - safety run-in and expansion) will be to reassess the maximum tolerated dose (MTD) defined in the Phase Ia stage in a framework of more extensive premedication, and to evaluate the antitumor activity of PM54 according to the RECIST v.1.1 (or mRECIST v.1.1 in case of MPM) and/or serum markers as appropriate, in patients with selected advanced solid tumors.

Conditions Studied

Advanced Solid Tumor

Interventions

  • DRUG PM54

Study Locations (3)

Texas

  • South Texas Accelerated Research Therapeutics - San Antonio

Other

  • Institut Jules Bordet - Anderlecht

M

  • HM Universitario Sanchinarro - Madrid

Trial Details

FieldValue
Enrollment Target 125 participants
Start Date 2023-04-28
Est. Completion 2027-04-30
Phase Phase 1

Sponsor

PharmaMar

32 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05841563

The ClinicalTrials.gov registry entry for NCT05841563 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 192-participant average among 189 other Advanced Solid Tumor trials with a reported enrollment target (35% lower). The listed sponsor is PharmaMar, which has 32 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Advanced Solid Tumor appearing as the primary indexed condition, and to 1 intervention - of which PM54 is the first listed.

NCT05841563 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Texas, Other, M.

Frequently Asked Questions

What is clinical trial NCT05841563 about?

NCT05841563 is a clinical study titled "Clinical Trial of PM54 in Advanced Solid Tumors Patients.". The first part of the study (phase Ia - dose escalation) will evaluate the safety and tolerability and identify the dose-limiting toxicities (DLTs) of PM54. The second part of the study (phase Ib - safety run-in and expansion) will be to reassess the maximum tolerated dose (MTD) defined in the Phas...

What is the current status of trial NCT05841563?

This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 125 participants. The study started on 2023-04-28. Estimated completion is 2027-04-30.

What conditions does trial NCT05841563 study?

This clinical trial studies the following conditions: Advanced Solid Tumor.

What interventions are being tested in trial NCT05841563?

The interventions under investigation include: PM54 (DRUG).

Who is sponsoring clinical trial NCT05841563?

This trial is sponsored by PharmaMar, which has 32 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05841563 being conducted?

This trial has 3 study locations across Texas, M. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Advanced Solid Tumor

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Advanced Solid Tumor

All registered trials for this condition

Texas

All trials with a study site in Texas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.